Skip to main content

台大化工系網站英文版

Bulletin

2015/05/29 講者: 姚少凌教授 講題: Serum-free expansion, induction and pre-clinical application of human hematopoietic stem cells







 
講者:姚少凌教授

演講題目:Serum-free expansion,induction and pre-clinical application of human hematopoietic stem cells

演講時間:5/29(五)15:30~17:20

演講地點:普通教室 101

主持人:萬本儒教授

Serum-free expansion, induction and pre-clinical application of human hematopoietic stem cells

 

Chao-Ling Yao (姚少凌)

 

1Department of Chemical Engineering and Materials Science (元智大學化材系);

 

2Graduate School of Biotechnology and Bioengineering (元智大學生技所),

 

Yuan Ze University

 

          Cord blood (CB) has been identified as a rich source of hematopoeitic stem cells (HSCs) available for transplantation. Since the first case of Fanconi’s anemia patient received successful CB transplantation in 1988, more than 6,000 patients have been performed. The advantages of using CB as HSC sources comparing with traditional bone marrow are following: 1) There is no harm to the donor. 2) There is significantly reduced level of graft-verse-host disease. 3) There is low contamination rate/ risk with common viruses, such as CMV and EBV. 4) Mature processing and banking system for storage and management. 5) Cost efficient for transplantation process. However, the limitation of CB transplantation is the insufficient cell number in the collected CB unit.

 

          In order to solve the shortage of cell number in CB, we developed an optimized serum-free medium for ex vivo expansion of HSCs from UCB. Besides, the serum-free expanded HSCs were further to be induced into natural killer (NK) cells, megakaryocytes (MKs), macrophage and red blood cells specifically. Here, we would briefly introduce the results of the serum-free expanded HSCs and their differentiated cells according to their future applications, such as HSC transplantation, cell therapy, immunotherapy, cell-based test platform and humanized mice establishment, respectively.


 

關於本次演講資訊請參考附件檔案,謝謝。


 


 

 
相關連結下載